Feature

Research Report

Electronic Consultations for Subspecialists: A Potential Virtual Pathway for Patient Clinic Visits

03/15/2021

Joshua D Hickman, MHA

Megan M Colgan, BA

Michelle M L’Heureux, MD, FACP

Christopher H Lowrey, MD

Kenneth R Meehan, MD

Abstract: With the onset of the COVID pandemic, computer-assisted clinic visits and telemedicine have become a critical aspect of patient care. As a rural National Cancer Institute-designated cancer center, the...

...

03/15/2021

Journal of Clinical Pathways

Research Report

Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer

02/22/2021

Karen A Sereday, MS

David C Boulware, MS

Sandra C Stewart, CTR

Yaroslav Shtogun, PhD

Dung-Tsa Chen, PhD

Ashley A Durand, MS

Peter AS Johnstone, MD

Julio M Pow-Sang, MD

Tracy C Simpson

Dana E Rollison, PhD

Karen K Fields, MD

Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...

...

02/22/2021

Journal of Clinical Pathways

Research Reports

The Impact of a Clinical Decision Support System for Advanced Gastric or Gastroesophageal Junction Cancer

12/16/2020

Scott Paulson, MD

Lisa M Hess, PhD

Anindya Chatterjee, PhD

Marley Boyd, MS

Kathleen M Aguilar, MPH

Astra M Liepa, PharmD

Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult patients...

...

12/16/2020

Journal of Clinical Pathways

From the Field

Feasibility of Transitioning to Virtual Multidisciplinary Thoracic Tumor Board

12/16/2020

Erik Stiles, MSc

Chelsea Jackson, RN

David L Coy, MD, PhD

Joseph Rosales, MD

Steven Kirtland, MD

Michal Hubka, MD

Abstract: Delay in management of thoracic malignancies and lung nodules can result in poor clinical outcomes. Multidisciplinary tumor boards (MTBs) represent a standard of care that must evolve in the setting of...

...

12/16/2020

Journal of Clinical Pathways

From the Field

Update on the Evolution of The US Oncology Network’s Clinical Pathways Program

11/18/2020

Aimee Ginsburg, PharmD, BCPS

Marcus Neubauer, MD

Lalan Wilfong, MD

Abstract: The National Comprehensive Cancer Network (NCCN) Guidelines are seen as the most comprehensive and most frequently updated cancer clinical practice guidelines available. Clinical pathways have a narrower...

...

11/18/2020

Journal of Clinical Pathways

Perspectives

Approaching Clinical Pathway Development as an Art

11/18/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD

Craig Ornstein, PhD

Seth Gordon, MBA

Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders—clinically and...

...

11/18/2020

Journal of Clinical Pathways

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Lalan Wilfong, MD

Aimee Ginsburg, PharmD, BCPS

J Russell Hoverman, MD, PhD

John M Burke, MD

Leslie T Busby, MD

Angela Hsieh, PharmD, BCOP

Kartik Konduri, MD

Marcus A Neubauer, MD

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Perspectives

Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery

10/21/2020

Barbara McAneny, MD

Lee Schwartzberg, MD, FACP

Wui-Jin Koh, MD

Edward Arrowsmith, MD

Alison Fugaro, PA

Tyler Haydell

Paul J Hesketh, MD

Anita Pudusseri, DO

Sylvia Richey, MD

Corrine Zarwan, MD

Rebecca Stein

Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...

...

10/21/2020

Journal of Clinical Pathways

From the Field

Developing Pathway to Cure: A Multimodal Clinical Pathway Platform to Support Timely and Appropriate Care of Women Under 50 Diagnosed With Breast Cancer

09/18/2020

Robin M Lally, PhD, MS, RN, AOCN, FAAN1,2

Roksana Zak, PhD1

Ryan Ramaekers, MD3

Allison F Coates, BS, BSN, RN1

Elizabeth Reed, MD2

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Perspectives

Primary Care Increasingly on the Front Lines of Clinical Genetics: Standard Practice and Data Concerns

09/18/2020

Joel Diamond, MD, FAAFP

Abstract: Many health care leaders find themselves in an unexpected situation as market awareness around precision medicine grows: primary care providers increasingly have become the front line for genetic and...

...

09/18/2020

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products